학술논문
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer
Document Type
Article
Author
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 10 December 2020, 63(23):14609-14625)
Subject
Language
English
ISSN
15204804
00222623
00222623